Cite

HARVARD Citation

    Brunton, S. et al. (2014). Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, for the Management of Type 2 Diabetes. Hospital practice. 42 (3), pp. 96-108. [Online]. 
  
Back to record